My ePortfolio Register   

Focus on screening, not biomarkers

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.12.17
Views: 743

Dr Hain Van Poppel - European Association of Urology, Arnhem, The Netherlands

Hain Van Poppel talks to ecancer at EAPM 2017 in Belfast.

He underlines the problems surrounding the costs and relatively low success of drug development in prostate cancer.

He believes strongly that there is not enough emphasis on screening, and too much focus on biomarkers.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence